Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey

BMC Cancer, 05/10/2012

The proportion of CML patients who sensed a financial burden increased between 2000 and 2008. During this period, their annual incomes fell by 13,000 USD, although their medical expenses did not change. Financial support for patients being treated with expensive drugs remains a major problem in Japan.

Print Article Summary Cat 2 CME Report